By Josh White
Date: Monday 31 Mar 2025
(Sharecast News) - AstraZeneca announced on Monday that it secured a US regulatory approval and a positive EU recommendation for two of its oncology therapies, Imfinzi and Calquence, marking progress in its immunotherapy and haematology pipelines.
Director/PDMR Shareholding | 31-Mar-2025 | 14:09 | RNS |
Form 8.3 - Aviva PLC | 31-Mar-2025 | 14:03 | RNS |
Total Voting Rights | 31-Mar-2025 | 14:00 | RNS |
Total Voting Rights | 31-Mar-2025 | 14:00 | RNS |
BOCOM Proposed Issuance of A Shares | 31-Mar-2025 | 14:00 | RNS |
Next eyes lift in profits as sales grow | 31-Dec-2014 | The Herald |
Special dividend from Next after online sale boost | 31-Dec-2014 | The Scotsman |
Business Next Next emerges as a Christmas winner | 31-Dec-2014 | Guardian |
MARKET REPORT: Royal Mail posts 5% rise | 31-Dec-2014 | Express & Star |
BAE driving forward for apprentices | 31-Dec-2014 | Express & Star |
Questor:Meggitt | 23-Dec-2014 | Telegraph |
Questor:Babcock | 19-Dec-2014 | Telegraph |
Questor :Aberdeen Asset Management | 03-Dec-2014 | Telegraph |
Questor :Petrofac | 26-Nov-2014 | Telegraph |
Questor :Royal Mail | 21-Nov-2014 | Telegraph |
Price | 8,549.62 |
Change Today | -109.23 |
% Change | -1.26 % |
28-Mar-25 Close | 8,658.85 |
You are here: research